SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+1.84%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.59B
AUM Growth
+$1.59B
(-1.7%)
Cap. Flow
+$31.4M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
62.27%
Holding
81
New
13
Increased
16
Reduced
16
Closed
16
Top Buys
| 1 |
Bolt Biotherapeutics
BOLT
|
$90.6M |
| 2 |
Eli Lilly
LLY
|
$26.8M |
| 3 |
NextCure
NXTC
|
$26.7M |
| 4 |
Align Technology
ALGN
|
$24.6M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$23.6M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$75.8M |
| 2 |
AbbVie
ABBV
|
$31.5M |
| 3 |
Amgen
AMGN
|
$31.3M |
| 4 |
United Therapeutics
UTHR
|
$22.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$14.4M |
Sector Composition
| 1 | Healthcare | 97.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-164,625
| Closed | -$8.8M |
|
|
77
AbbVie
ABBV
$374B
| – | – |
-293,596
| Closed | -$31.5M |
|